Drug Database
Back to search

Netherlands· NL-d80acaee9663

Spexotras 0,05 mg/ml poeder voor drank

A trametinib product containing trametinibdimethylsulfoxide, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 12 of our 19 countries.

ATC L01EE01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSpexotras 0,05 mg/ml poeder voor drankATCL01EE01REGISTER NO.NL-d80acaee9663PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trametinibdimethylsulfoxideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trametinib is registered in 12 of 19 countries.

Countries holding a registration under ATC L01EE01 (trametinib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search trametinib products by name

Trametinib · ATC L01EE01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trametinib costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Trametinib · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$215.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRAMETINIBDIMETHYLSULFOXIDE
Manufacturer
Novartis Europharm Limited
Country
Netherlands (NL)
ATC code
L01EE01
ATC class
Trametinib
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/23/1781

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

22 interactions on record for trametinib.

Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check trametinib against other medicinesHow interaction checks work

Trametinib · interactions on record

22 records

  • 22 moderate

Most severe, free to view

  • FostamatinibB02BX09moderate
  • ElagolixH01CC03moderate
  • SarecyclineJ01AA14moderate
  • IsavuconazoleJ02AC05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trametinib in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trametinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Mekinist, Spexotras
  • Liechtenstein · Mekinist, Spexotras
  • Norway · Mekinist, Spexotras

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a91564f7-799e-44c0-92c9-628f8f947e88
GET /v1/drugs/a91564f7-799e-44c0-92c9-628f8f947e88?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor drank",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/spexotras-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Trametinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130490",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "ARABISCHE GOM (E 414)",
    "CITROENZUUR 1-WATER (E 330)",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "KALIUMSORBAAT (E 202)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "SUCRALOSE (E 955)",
    "SULFOBUTYLETHER BETA-CYCLODEXTRIN NATRIUM"
  ],
  "substances": [
    "TRAMETINIBDIMETHYLSULFOXIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/01/05",
  "procedure_number": "EMEA/H/C/005886",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1781",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about trametinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console